| http://www.w3.org/ns/prov#value | - Among patients with type 2 diabetes, initiating DPP4i combination therapy may be associated with a decreased risk of rheumatoid arthritis or other autoimmune diseases compared to initiating non-DPP4i combination therapy, explains Dr. Kim.
|
